Fabry disease pre-treatment patterns in United States claims data
Alexandra Dumitriu(Pfizer (United States)), Roberto Araujo, Gandarvaka Miles(Sanofi (United States)), Michael B. Jordan(Cincinnati Children's Hospital Medical Center), Queeny Ip, Ana Crespo, И. А. Максимова(Lomonosov Moscow State University), Andrea Ocampo, Natalia Petruski‐Ivleva(AVEO Oncology (United States))
Cited by 0
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Dietary Protein Sources and Risk for Incident Chronic Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study
|Journal of Renal Nutrition|2017|254
Allogeneic hematopoietic cell transplantation for XIAP deficiency: an international survey reveals poor outcomes
|Blood|2012|144
The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis
|Blood|2016|106
Incidence, prevalence and mortality of IgG4-related disease in the USA: a claims-based analysis of commercially insured adults
|Annals of the Rheumatic Diseases|2023|95